Caredx Inc (NASDAQ:CDNA) price on Thursday, May 01, fall -10.72% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $15.07.
A look at the stock’s price movement, the close in the last trading session was $16.88, moving within a range at $14.8565 and $17.14. The PE ratio in trailing twelve months stood at 14.82. Turning to its 52-week performance, $34.84 and $8.43 were the 52-week high and 52-week low respectively. Overall, CDNA moved -14.86% over the past month.
Caredx Inc’s market cap currently stands at around $837.84 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-29.
Analysts have a consensus estimate of 90.53M for the company’s revenue for the quarter, with a low and high estimate of 89.5M and 91.83M respectively. The average forecast suggests down to a -1.89% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 370.82M, representing a 11.09% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CDNA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CDNA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CDNA’s current price about -15.66% and -20.15% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.64, while 7-day volatility ratio is 7.02% and 7.71% in the 30-day chart. Further, Caredx Inc (CDNA) has a beta value of 2.27, and an average true range (ATR) of 1.24. Analysts have given the company’s stock an average 52-week price target of $30, forecast between a low of $25 and high of $35. Looking at the price targets, the low is -65.89% off current price level while to achieve the yearly target high, price needs to move -132.25%. Nonetheless, investors will most likely welcome a -99.07% jump to $30 which is the analysts’ median price.
If we refocus on Caredx Inc (NASDAQ:CDNA), historical trading data shows that trading volumes averaged 1.01 over the past 10 days and 824.35K over the past 3 months. The company’s latest data on shares outstanding shows there are 54.77 million shares.
The 6.95% of Caredx Inc’s shares are in the hands of company insiders while institutional holders own 104.34% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.05 million on 2025-04-15, giving us a short ratio of 9.03. The data shows that as of 2025-04-15 short interest in Caredx Inc (CDNA) stood at 1424.9999999999998 of shares outstanding, with shares short rising to 5.74 million registered in 2025-03-14. Current price change has pushed the stock -29.61% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CDNA stock continues to rise going into the next quarter.
